Yanase T, Sekiya K, Ando M, Nawata H, Kato K, Ibayashi H
Acta Endocrinol (Copenh). 1985 Sep;110(1):36-41. doi: 10.1530/acta.0.1100036.
A 61 year old Japanese man with a diagnosis of Addison's disease was admitted to Kyushu University Hospital for further investigation of high ACTH levels and hyperpigmentation which 37.5 mg of cortisone acetate failed to alleviate. The basal level of plasma ACTH was 700-1000 pg/ml, and following 25-37.5 mg cortisone acetate or 1 mg dexamethasone the levels were 300-600 pg/ml. The general pigmentation showed little improvement with such medication. Radiographic studies revealed a double floor of the sella turcica and cisternal herniation. These observations suggested the existence of a pituitary ACTH-secreting tumour. Plasma ACTH showed a circadian rhythm ranging from 440 to 1570 pg/ml and it was not suppressed to a normal range by oral administration of dexamethasone, 8 mg/day or by continuous infusion of dexamethasone, 1.25 mg/h for 2 h. Plasma ACTH responses of 80% above basal level to lysine-vasopressin (LVP), and 12% above basal to synthetic ovine corticotrophin releasing factor (CRF) were observed. FK 33-824, a methionine-enkephalin analogue, suppressed plasma ACTH to 85% of basal level, while bromocriptine (CB-154) caused no significant change. These findings led to a diagnosis of pituitary ACTH-secreting adenoma (corticotropinoma) in association with Addison's disease. The persistent circadian rhythm of plasma ACTH suggested that this adenoma may not be completely free from regulation by the central nervous system. This case may be clinically significant for investigation of the pathogenesis of pituitary adenoma, particularly in Nelson's syndrome.
一名61岁被诊断为艾迪生病的日本男性因高促肾上腺皮质激素(ACTH)水平和色素沉着加剧而入住九州大学医院,此前37.5毫克醋酸可的松未能缓解这些症状。血浆ACTH基础水平为700 - 1000皮克/毫升,服用25 - 37.5毫克醋酸可的松或1毫克地塞米松后,水平为300 - 600皮克/毫升。这种药物治疗后,全身色素沉着几乎没有改善。影像学研究显示蝶鞍双底和脑池疝。这些观察结果提示存在垂体ACTH分泌肿瘤。血浆ACTH显示出昼夜节律,范围为440至1570皮克/毫升,口服8毫克/天的地塞米松或持续输注1.25毫克/小时的地塞米松2小时后,其水平未被抑制至正常范围。观察到血浆ACTH对赖氨酸加压素(LVP)的反应比基础水平高80%,对合成羊促肾上腺皮质激素释放因子(CRF)的反应比基础水平高12%。甲硫氨酸脑啡肽类似物FK 33 - 824将血浆ACTH抑制至基础水平的85%,而溴隐亭(CB - 154)未引起显著变化。这些发现导致诊断为垂体ACTH分泌腺瘤(促肾上腺皮质激素瘤)合并艾迪生病。血浆ACTH持续的昼夜节律表明该腺瘤可能并未完全不受中枢神经系统的调节影响。该病例对于垂体腺瘤发病机制的研究可能具有临床意义,尤其是在纳尔逊综合征方面。